Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


Free Access

The Assessment of Newborn Iron Stores at Birth: A Review of the Literature and Standards for Ferritin Concentrations

Siddappa A.M.a · Rao R.b · Long J.D.c · Widness J.A.d · Georgieff M.K.b

Author affiliations

aDivision of Neonatology, Hennepin County Medical Center, and Department of Pediatrics, University of Minnesota School of Medicine, bDivision of Neonatology, Department of Pediatrics, University of Minnesota School of Medicine, and cDepartment of Educational Psychology, College of Education and Human Development, University of Minnesota, Minneapolis, Minn., dDivision of Neonatology, Department of Pediatrics, University of Iowa School of Medicine, Iowa City, Iowa, USA

Corresponding Author

Michael K. Georgieff, MD

MMC 39, D-136 Mayo Building

420 Delaware St. SE

Minneapolis, MN 55455 (USA)

Tel. +1 612 626 2971, Fax +1 612 624 8176, E-Mail georg001@umn.edu

Related Articles for ""

Neonatology 2007;92:73–82

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Background: Serum ferritin measurements are used in clinical populations to estimate total body iron stores and the risk of subsequent iron deficiency or overload. The lack of normative newborn serum ferritin concentration data between 23 and 41 weeks has led to difficulty in establishing the incidence and degree of abnormal iron status in the neonatal period. Objectives: The primary objective of this review was to summarize the maternal and gestational factors that determine ferritin concentrations in full-term and pre-term newborn infants and to generate comprehensive reference values. The secondary objective was to assess serum ferritin concentrations in newborn infants at risk for abnormal fetal iron metabolism, including maternal diabetes mellitus, intrauterine growth restriction and maternal smoking during pregnancy. Methods: Serum ferritin and gestational age data at birth from 457 low-risk pre-term and term infants of 23–41 weeks gestation obtained from 35 published studies reviewed from a period of 25 years and from recently collected data from our centers were assessed by regression analysis. Slopes and intercepts of the high-risk groups were compared with the standard curve. Results: Umbilical cord serum ferritin concentrations increased with advancing gestational age, from a mean of 63 µg/l at 23 weeks to 171 µg/l at 41 weeks gestation (p < 0.001). The infants of diabetic mothers had a lower intercept than the control infants (p < 0.001). Conclusions: Iron deficiency and overload have been implicated in neurodevelopmental impairments. Normative cord serum ferritin data may permit a more precise assessment of infants who are at risk for abnormal iron status at birth.

© 2007 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Review

Received: July 11, 2006
Accepted: December 17, 2006
Published online: March 14, 2007
Issue release date: August 2007

Number of Print Pages: 10
Number of Figures: 2
Number of Tables: 2

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: http://www.karger.com/NEO

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.